Every 10-Q that Arteris, Inc. (AIP) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow AIP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AIP filings page.
Arteris, a provider of Network-on-Chip and SoC integration IP, reported strong top-line growth but remained unprofitable for the three months ended June 30, 2026. Revenue was $24,134 (in thousands), up from $16,502 (in thousands) a year earlier, led by licensing, support and maintenance of $20,824 (in thousands) and variable royalties of $2,103 (in thousands). Net loss widened to $14,065 (in thousands), or $0.30 per share, as operating expenses rose to $34,435 (in thousands), including higher research and development and $2,215 (in thousands) of acquisition-related costs.
For the first half of 2026, revenue reached $47,070 (in thousands) with a net loss of $22,024 (in thousands). The January 2026 acquisition of Cycuity added security-focused software, with total purchase consideration of $43,126 (in thousands), identifiable intangibles of $18,070 (in thousands) and goodwill of $31,121 (in thousands), and contributed to a $4,103 (in thousands) income tax benefit. Cash and cash equivalents increased to $93,270 (in thousands), aided by an at-the-market equity program that raised net proceeds of $72,000 (in thousands). Total assets more than doubled to $224,713 (in thousands), deferred revenue grew to $108,857 (in thousands), and stockholders’ equity improved from a deficit of $14,632 (in thousands) at year-end 2025 to positive equity of $67,674 (in thousands). Remaining performance obligations were $131,400 (in thousands), with $67,500 (in thousands) expected to be recognized within 12 months.
Arteris, Inc. reported Q1 2026 results showing higher revenue but continued losses while integrating its Cycuity acquisition. Revenue rose to $22.9 million from $16.5 million a year earlier, led by licensing, support and maintenance and stronger variable royalties.
The company recorded a net loss of $8.0 million, or $0.17 per share, roughly in line with the prior-year loss. Operating cash flow swung to an outflow of $7.1 million, and cash and cash equivalents declined to $11.7 million, partly reflecting deal-related spending.
Arteris closed the $43.1 million Cycuity transaction, adding $18.1 million of intangible assets and increasing goodwill to $35.2 million. Annual Contract Value reached $84.9 million, with ACV plus royalties at $92.8 million and Remaining Performance Obligations at $118.3 million, indicating a growing base of contracted future revenue.
Arteris, Inc. (AIP) reported Q3 2025 results with total revenue of $17.4 million, up from $14.7 million a year ago as licensing, support and maintenance reached $15.9 million and variable royalties were $1.5 million. Gross profit was $15.6 million on a 90% gross margin profile. Operating expenses rose to $24.4 million, leading to a net loss of $9.0 million versus $7.7 million last year, or $0.21 per share.
The company ended September 30, 2025 with $17.4 million in cash and cash equivalents and $43.2 million in total investments. Deferred revenue was $85.9 million, and remaining performance obligations were $104.7 million. Annual Contract Value was $69.4 million, with ACV plus royalties at $74.9 million as of September 30, 2025. Net cash provided by operating activities for the nine months was $3.6 million.
Arteris reported 23 Confirmed Design Starts in the quarter. As of October 28, 2025, there were 43,683,773 common shares outstanding. In litigation, on September 4, 2024, a Texas federal court dismissed all claims against the company without prejudice in the NST matter.